There was a trend ( P = 0.13) toward reduced hemoglobin A1c after treatment compared to pre-treatment [ Figure 2c ], but this did not reach statistical significance, likely due to the small sample size.
← all excerpts
The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MASLD.
1
—
—